Fluorine F 18 FEQA

Preferred Label : Fluorine F 18 FEQA;

NCIt synonyms : N-{4-[(3'- [F-18] Fluoroethylphenyl)amino]-6-quinazolinyl}-acrylamide; F-18 FEQA;

NCIt related terms : N-(4-((3'-(F-18)FLUOROETHYLPHENYL)AMINO)-6-QUINAZOLINYL)ACRYLAMIDE;

NCIt definition : The anilinoquinazoline derivative FEQA radiolabeled with the positron-emitting radioisotope fluorine F 18 with epidermal growth factor receptor (EGFR) binding and radioisotopic activities. Fluorine F 18 FEQA irreversibly binds to EGFR, allowing imaging of EGFR-positive tumor cells with positron emission tomography (PET).;

Alternative definition : NCI-GLOSS: A radioactive substance being studied in positron emission tomography (PET) imaging to detect cancer and to monitor the response of some types of cancer to treatment. Fluorine F 18 FEQA attaches to the epidermal growth factor receptor (EGFR) found on the surface of some tumor cells. It is a type of radiopharmaceutical.;

UNII : NL5263JX7B;

InChIKey : DOTPWDSTLRNTIK-LRFGSCOBSA-N;

Codes from synonyms : CDR0000540457;

Details

Origin ID

C66936;

UMLS CUI

C1880812;

Semantic type(s)
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
has_target
- Epidermal Growth Factor Receptor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients